Target intelligence / Profile preview

Candida albicans recognition receptors

Molecular classification
Receptor, C-type lectin receptor, Toll-like receptor, Antigen receptor
01

Overview

Candida albicans recognition receptors represent a complex network of immune sensors that identify fungal cell wall components and proteins to initiate a host defense. This group includes innate pattern recognition receptors (PRRs) such as Dectin-1 (CLEC7A), which binds beta-1,3-glucans, and Dectin-2 (CLEC6A) and Mincle (CLEC4E), which recognize alpha-mannans (Gow et al., 2012, Nature Reviews Microbiology). Toll-like receptors, specifically TLR2 and TLR4, also contribute by sensing phospholipomannans and O-linked mannans (Netea et al., 2008, Trends in Immunology). Furthermore, the adaptive immune system utilizes B-cell receptors (BCRs) and T-cell receptors (TCRs) to recognize specific fungal epitopes like the Als3 adhesin, which is a primary target for vaccine development (Edwards et al., 2018, Clinical Infectious Diseases). These receptors collectively orchestrate phagocytosis, the respiratory burst, and the secretion of critical cytokines such as IL-6, IL-23, and IL-17, which are vital for clearing fungal infections. Therapeutic strategies targeting these receptors include immunomodulators like beta-glucans and vaccines designed to enhance protective Th1/Th17 responses in immunocompromised individuals.

Other names
Candida-sensing receptorsFungal pattern recognition receptorsC. albicans PRRsInnate and adaptive fungal receptors
02

Mechanism of action

Activation of innate pattern recognition receptors and adaptive antigen receptors to stimulate antifungal effector functions, including Th17 differentiation and antibody production.

03

Biological functions

Immune responseSignal transductionPhagocytosisCytokine productionCell activation
04

Disease associations

InfectionCandidiasisInflammationAutoimmune disease
05

Safety considerations

Risk of systemic inflammatory response syndrome (SIRS)Potential for autoimmune cross-reactivity with host tissuesExacerbation of inflammatory bowel disease (IBD)Hyperinflammation-induced tissue damage
06

Interacting drugs

Beta-glucan

4 more in the full profile.

07

Biomarkers

Dectin-1 (CLEC7A) expression levelsInterleukin-17 (IL-17) serum levelsAnti-Candida antibody titersDectin-1 Y238X polymorphism status

Beyond the preview

Go deeper on Candida albicans recognition receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candida albicans recognition receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call